MedTrace Logo

Cognitive Changes Associated With Breast Cancer Treatment

NCT00550134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-12-30

No results posted yet for this study

Summary

Patients with cancer often complain that their "mind does not seem to be clear." This can be due to stress, depression, anxiety, or physical problems caused by cancer or the treatments used to control symptoms. There are many purposes for this study; one of them is to learn about the effects of cancer treatments on the brain, and another is to identify useful tools to detect these effects. The results of this study may stimulate new research comparing different treatments to the current treatment so the researchers may learn how to treat symptoms more effectively and improve patient quality of life. We would also like to learn more about the effects chemotherapy may have on DNA.

Conditions

  • Breast Cancer
  • Cognitive Side Effects of Cancer Treatments
  • Stage I, II and III A Breast Cancer

Interventions

BEHAVIORAL

Questionnaires, MRI, Comet assay and Cell senescence

Neuropsychological and psychological testing MRI, Comet assay and Cell senescence

BEHAVIORAL

Questionnaires, MRI, Comet assay and Cell senescence

Neuropsychological and psychological testing MRI, Comet assay and Cell senescence

BEHAVIORAL

Questionnaires, MRI, Comet assay and Cell senescence

Neuropsychological and psychological testing, MRI, Comet assay and Cell senescence

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • The City College of New York

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Biomedical Engineering Newark College of Engineering New Jersey Institute of Technology

    collaborator UNKNOWN

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Tim Ahles, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-24
Primary Completion
2021-12-28
Completion
2021-12-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550134 on ClinicalTrials.gov